NCT04021290 Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA) Status COMPLETED Phase PHASE3
NCT04020341 A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) Status COMPLETED Phase PHASE3
NCT04010539 A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Status COMPLETED Phase PHASE3
NCT04007159 To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products Status COMPLETED Phase NA
NCT04006808 A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant Status RECRUITING Phase PHASE1/PHASE2
NCT04006795 A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and Lotion Status COMPLETED Phase NA
NCT03992014 Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat Status COMPLETED Phase PHASE1
NCT03987295 A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2) Status COMPLETED Phase PHASE2
NCT03983993 Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03980483 Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3
NCT03975361 Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE) Status UNKNOWN Phase NA
NCT03973905 Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States Status COMPLETED Phase N/A
NCT03970837 Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) Status TERMINATED Phase PHASE3
NCT03967925 Rituximab and Belimumab Combination Therapy in PR3 Vasculitis Status UNKNOWN Phase PHASE2
NCT03965533 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects Status COMPLETED Phase PHASE1
NCT03960255 Effect of Adiposity and Associated Local Microbial Factors on Healing and Progression of Diabetic Foot Ulcers Status UNKNOWN Phase N/A
NCT03957577 Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan Status COMPLETED Phase N/A